|
WHAT IS
BATTEN DISEASE?
As a rare, fatal, inherited disorder of the nervous system, Batten disease has no treatment or cure. It is the most common, inherited neurodegenerative disorder found in children, and is also known as a group of disorders called the neuronal ceroid lipofuscinoses (NCLs). Batten disease occurs in approximately 2-4 births per 100,000 in the United States.

There are multiple forms of the disease, which is most commonly diagnosed between infancy and school age. The three most common forms of Batten disease are infantile NCL, late infantile NCL, and juvenile NCL. Children with Batten disease have typical growth and development until early symptoms appear. The loss of previously acquired skills and regression of developmental milestones are frequently the initial signs of the disease. Those affected suffer progressive neurological impairment, which includes seizures, blindness, personality and behavior changes, memory loss and dementia, the loss of motor skills and the ability to walk, talk, and communicate. The arc of the disease can vary tremendously for each patient. The diagnostic process to identify Batten disease can often take years, as the disease is frequently misidentified in the early stages.
|
 |
BATTEN AWARENESS WEEKEND:
June 7 & 8, 2014
|
 |

is the largest nonprofit organization in North America dedicated to funding research, advancing education, providing family support services, and raising awareness of the disease and its impact. Founded in 1987, a focus of the BDSRA is to help unravel the mysteries of Batten disease by bringing the worlds of science, research, and health care together toward a common goal: the discovery of treatments and cures.
PROGRAMS
BDRSA programs are designed to:
-Maximize opportunities for Batten families to manage the disease and its impact through medical, educational, and support resources.
-Educate caregivers, medical professionals, teachers, and the public about the special health care needs of those diagnosed with Batten disease.
-Connect Batten families to appropriate resources to meet a wide variety of needs related to special education accommodations and specialized care within their own communities.
Follow the links to learn more about each one:
~Centers of Excellence
(July 24-27, 2014 in Columbus, OH)
~Testing Centers
~Family Stories
RESEARCH
In May 2014, BDSRA,
in collaboration with international and family foundation partners, announced grants totaling $408,000 to advance the development of treatments and cures for Batten disease.
READ THE FULL ARTICLE HERE.
BDSRA research programs:
-Fund cutting-edge technologies, including new developments in
gene therapy, enzyme replacement, and drug discovery.
-Provide for the continued development
of an international Batten Disease Registry and natural history data project to ensure the rapid distribution of information to labs and scientists across the globe.
-Support both basic and applied laboratory studies to accelerate the pathway to clinical trials and treatments through collaborations with biotech and pharmaceutical partners.
ADVOCACY
BDSRA builds alliances and networks across state and federal legislative channels to raise awareness about rare disease and the needs of Batten families. By educating policymakers and government leaders, BDSRA adds a unified voice to advocate for research funding and the need to expand the drug discovery process.
|
 |
|

|
|
|
|
|
Greetings!
Welcome to Families First, the CNF e-newsletter for parents and caregivers of children with neurologic conditions. We have some exciting news to share with you this quarter:
~The announcement of the John & Laurian Scott Heroes of Promise Award, an annual award that will honor the role of parents as partners in the delivery of optimal care to children with neurologic conditions 
~A look at Batten Disease and the information and resources available through the Batten Disease Support & Research Association (BDSRA).
Happy Summer to You and Your Loved Ones!
|
 |
|
CHILD NEUROLOGY HEROES DINNER
Saturday, November 8, 2014
Four Seasons Hotel: Beverley Hills, CA
We've come to think of Heroes as imaginary creatures, somehow separate from our daily reality. Yet our humanity beckons us to believe we can battle against the unjust problems of today and win. In essence, we beg for the arrival of Heroes.
Since 2001, the Child Neurology Foundation (CNF) has been working to ensure children living with neurologic disorders receive optimal care. One-in-four children in the United States lives with a neurologic disease - ranging from Autism and Epilepsy to rare neuromuscular diagnoses. These 18 million affected children, and their families, are asked daily to be their own Heroes; and, in doing so, they have become ours.
John and Laurian Scott know the reality of caring for a child living with neurologic disease. Their daughter Thisbe began showing the signs of a rare neuromuscular disorder when she was 16-months. It was a disease that robbed her body the joys of being a little girl, making her dependent on machines to eat and breathe. Just shy of her third birthday, Thisbe took her last breath; and her parents promised never again. But again came too soon as their younger son Noah began to have the symptoms of the same rare neuromuscular disorder just one month later. This unthinkable nightmare continued with Noah's death a year after his sister's. Two children. One promise. In the following years, John and Laurian worked towards fulfilling their promise; and, in 2011, it was realized when the gene causing this deadly disease was identified. This research feat subsequently allowed them to have two healthy children and set forth this same possibility for future families. Heroes didn't have to show up for John and Laurian; they simply stood up.
And they aren't alone. To celebrate the Heroes that care for children afflicted with neurologic disease, the CNF will be hosting A Heroes Dinner on Saturday, November 8, 2014 at The Four Seasons - Beverly Hills. This evening reception will announce the establishment of The John & Laurian Scott - Heroes of Promise Award. It is an award that begs us to not only honor the promise they made to their late children, but to also make one to ourselves. A promise to show up when the unthinkable happens. A promise to be the Hero that lingers within. A promise to say never again. After all, our children deserve to see Heroes every day.
Please CLICK HERE to learn how you can be part of A Heroes Dinner.
|
 |
The ChildNeuroChannel is a new, made-for-parents website with information, success stories, an event calendar, an "Ask the Principle" column, and even a children's corner with apps. and games. The site features an "Experts Explain" section that contains articles written specifically for caregivers by preeminent child neurologists that provide relevant, understandable, need-to-know information related to the symptoms, diagnoses, and treatment of neurologic conditions in children. "These articles, while lay-friendly, aren't simply sound-bites; they cover the comprehensive knowledge that parents are seeking,"explained CNF President, Dr. Don Shields. "The role of being their child's strongest advocate requires current, accurate information."
This project brought CNF founder, Dr. Ken Swaiman, out of retirement. He sought out top child neurologists for each article, and the initial compilation includes epilepsy, febrile seizures, ADHD, autism, LGS, sleep disorders, breath holding, infantile spasms, language disorders, headaches, and cerebral palsy. Additionally, the site will highlight some of the many family success stories we hear about every day to provide you and your family with insight, inspiration, and support.
The site was designed to be viewed on any device, and we suspect many first-time users will visit while still in their doctor's waiting rooms. Please let us know what you think of the site by sending an email to info@cnfmail.org.
|
 |
BDSRA FUNDS CRUCIAL PROJECT TO EXPAND A BATTEN DISEASE
PATIENT REGISTRY
One of the most important steps toward finding effective medical treatments for Batten disease and advancing clinical research is to map out the ways in which the forms of the disease affect patients: the symptoms most commonly seen, how those symptoms progress, trends among and between genetic types, and what complications develop. To achieve this means collecting as much data as possible about all patients throughout the world affected by the disease and assembling it in a single database. By creating a framework to collect, analyze, and distribute this data, called a patient registry, the scientific community can accelerate basic discoveries from bench to bedside.
A patient registry database for Batten disease will describe for the first time the natural history and progression of the disease over a person's lifespan and provide insights on new symptoms that might have been previously overlooked or unidentified. The more patients who have information entered into a registry, the greater the chances are that research will produce results that benefit all affected. To prepare and advance clinical trials, a major priority for BDSRA in the past two years has been funding a project to expand a Batten patient registry. Currently in use in Germany, Finland, Italy, India, and the U.K., the registry, through BDSRA support, will be expanded to include the United States, Brazil, Argentina, Turkey, France, Norway, and Denmark.
Why is a registry important to Batten disease research?
Because the disease is so rare, no single country or organization can marshal sufficient numbers of patients to conduct generalizable clinical and translational research. The geographic isolation of patients has been a major challenge in recruiting patients into clinical trials. Identifying patients and gathering genetic test results and clinical status parameters for the many forms of Batten disease is time intensive and expensive. The DEM-CHILD registry project, led by Angela Schulz, MD, of Germany's Children's Hospital and University Medical Center Hamburg-Eppendorf, with BDSRA funding support, aims to collect the world's largest, clinically and genetically best characterized set of NCL patients.
Scientists and pharmaceutical companies are also more likely to conduct research on a given rare disease if they find a patient registry in place. Registries also assist in understanding the disease, recruiting patients for clinical trials, tracking genotype and phenotype associations, safety monitoring, identifying novel biomarkers and modifiers, and developing novel therapies for NCLs. The collection of Batten patient data will also assist in achieving earlier diagnosis and proactive interventions for those affected, increasing quality of life and supportive care. The collection of Batten patient data will also assist in achieving earlier diagnosis and proactive interventions for those affected, increasing quality of life and supportive care.
"The DEM-CHILD NCL Patient Database Consortium is deeply thankful for the financial support of BDSRA for this project," Dr. Schulz said. "In the consortium, NCL clinicians from 11 countries have agreed to collaborate internationally in collecting and analyzing NCL patient data," she added. "This extensive collection and analysis of clinical data of all NCL forms is the first worldwide attempt to do this. It will be of significant importance for the validation of experimental therapies. Batten patient families can share information about the existence of the registry project with their medical team to make them aware of the opportunity to participate in the registry.
|
 |
|
BDSRA CONTACT INFORMATION AND FAMILY SUPPORT SERVICES
BDSRA has an on-staff Family Resource Officer, Becky Hetteberg, MA/LISW, available to work with any and all families on issues related to Batten disease. Her email is
bhetteberg@bdsra.org.
Family support services include the annual family conference, community resource assistance, medical and carrier testing assistance, bereavement services, school educational consultant services, linkages to medical care and palliative care experts, and linkages to clinical trials for those seeking to participate.
In addition to their open Facebook page, BDSRA administers a closed Facebook page with over 650 members who seek direct networking, family support, advice, and inspiration from one another. Please contact BDSRA to learn more and join.
BDSRA's quarterly newsletter, The Illuminator, is free to all. See past issues here and complete the contact form here to become a regular subscriber.
If you have questions or would like to speak to a BDSRA staff member directly, please call 800-448-4570.
|
|
|
|
|